WHO Model List of Essential Medicines and developed countries: A comparison with the Lothian Joint Formulary

WHO Drug Information

Volumn 20, Issue 2, 2006, Pages 73-77

  Hems, Sharon ^a   Laing, Richard ^b  

^a ST JOHN'S HOSPITAL   (United Kingdom)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; ANTIALLERGIC AGENT; CHOLINESTERASE INHIBITOR; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DISINFECTANT AGENT; DIURETIC AGENT; MINERAL; MUSCLE RELAXANT AGENT; OXYTOCIC AGENT; VITAMIN;

CONFERENCE PAPER; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DRUG COST; DRUG EFFICACY; DRUG FORMULARY; DRUG SAFETY; HEALTH CARE COST; HEALTH CARE QUALITY; WORLD HEALTH ORGANIZATION;

EID: 34548092994     PISSN: 10109609     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. World Health Organization. WHO Medicines Strategy: countries at the core. 2004-2007. Geneva: 2004.
2. Laing R, Waning B, Gray A, et al. 25 years of the WHO essential medicines lists: progress and challenges. Lancet 2003; 361: 1723-29.
3. World Health Organization. The Selection and Use of Essential Medicines. Report of the WHO Expert Committee, 2003 (including the 13th Model List of Essential Medicines). Technical Report Series, No. 920. Electronic version available at http://www.who.int/medicines/
4. World Health Organization. The Selection and Use of Essential Medicines. Report of the WHO Expert Committee, March 2005 (including the 14th Model List of Essential Medicines). Technical Report Series, No. 933. Electronic version available at http://www.who.int/medicines/
5. WHO model formulary. Available at: http://www.who.int/medicines/
6. British National Formulary. Available at: http://www.bnf.org
7. Lothian Joint Formulary. Available at: http://www.ljf.scot.nhs.uk.
8. World Health Organization. Selection and Use of Essential Medicines. Available at http://www.who.int/medicines/
9. Procedure to update and disseminate the WHO Model List of Essential Medicines. 12th Expert Committee on the Selection and Use of Essential Medicines, 15-19 April 2002
10. Trouiller P, Torreele E, Olliaro P, et al. Drugs for neglected diseases: a failure of the market and a public health failure? Tropical Medicine and International Health 2001; 6: 945-951.
11. Ruxin J, Paluzzi JE, Wilson PA, et al. Emerging consensus in HIV/AIDS, malaria, tuberculosis, and access to essential medicines. Lancet 2005; 365: 618-21.
12. World Health Organization. World Health Report 2003. Geneva, 2003. http://www.who.int/who/2003
13. World Health Organization. World report on knowledge for better health. Strengthening health systems. Geneva, 2004.
14. Audit Scotland. Supporting prescribing in general practice - a progress report. June 2003.
15. Beggs SA, Cranswick NE, Reed MD. Improving drug use for children in the developing world. Arch Dis Child 2005; 90: 1091-1093.
16. Sevene E, Lewin S, Mariano A, et al. System and market failures: the unavailability of magnesium sulphate for the treatment of eclampsia and pre-eclampsia in Mozambique and Zimbabwe. BMJ 2005; 331: 765-9.
17. Aaserud M, Lewin S, Innvaer S, et al. Translating research into policy and practice in developing countries: a case study of magnesium sulphate for pre-eclampsia. BMC Health Services Research 2005; 5: 68.